How Is NASDAQ: ACST Stock Affected By The Release Of Capre?

Acasti Pharma Inc., a biopharmaceutical company, trades its shares under the symbol NASDAQ: ACST at The company’s focus is research, commercialization, and the development of prescription drugs using the omega-3 fatty acids that are derived from krill oil. The company is developing a cardiovascular drug, named CaPre ( Omega-3 phospholipid) that will be used to treat hypertriglyceridemia. This drug is a mixture derived from krill oil containing polyunsaturated fatty acids that are primarily made of omega-3 fatty acids, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA). This medicine will be useful in reducing triglycerides. It will be beneficial for low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol for patients suffering from severe conditions of hypertriglyceridemia.


As discussed the Acasti Pharma Inc., a biopharmaceutical company, trades its shares under the symbol NASDAQ: ACST. The average stock price for ACST was recently 3.617, with a low estimate of 1.052 and a high estimate of 6.98. Based on the reports from expert analysts, one should buy these stocks if planning to do so nowadays. From 5 analysts, four suggest to buy them, and the last one strongly recommends to buy these stocks. The volume of the stock has been significantly high recently due to the increased price of the stocks. More and more investors want to buy the stocks for this firm.

Why Acasti Pharma’s Stock Is Trading Higher Today?

The ACST stocks are trading quite higher than regular after the B.Riley FBR upgraded the stock from Neutral to Buy and announced a $2 per share price target.

Recently, the ACST stock was trading up at 62 cents 16.74%. The 52-week high for the stock has been 3.08 US dollars, which are. Quite high for this stock and the 52-week low is 25 cents, which is not very bad.

Acasti Pharma Provides Fiscal 2020 Year-End Business Update

ACST hosted a conference at 1 pm ET on June 29th, 2020, to discuss the 2020 Year-End Business Update. The company focused on the research, commercialization, and development of its prescription drug candidate CaPre. The phase 3 clinical trials for the drug ended on March 31st, 2020.


The ACST stock is traded under the NASDAQ firm. This is the second-largest stock exchange of New York after NYSE. It is among the biggest stock exchanges in the world. It’s not easy to trade their stocks under such big firms for any company. Some of the world’s biggest and most successful stocks are traded under NASDAQ from trade desk stock. Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.